Masoud Manjili, D.V.M., Ph.D.
Research program member: Cancer Cell Signaling
401 College St.
Richmond, VA 23298
Professor, Pathology, School of Medicine
DVM, University of Tehran, Iran (1990)
PhD, University of Sydney, Australia (1996)
Immunotherapy of tumor dormancy Immune modulation during diet-induced progression of fatty liver disease to hepatocellular carcinoma.
Immunotherapy, tumor dormancy, tumor immunoediting, personalized vaccine, breast cancer